Domperidone Market: Size, Share, Growth, Analysis, Key Players, Revenue, Growth | Valuates Reports

Domperidone Market
Domperidone tablet is a peripheral dopamine receptor blocker, which directly acts on gastrointestinal wall. It can increase the tension of lower esophageal sphincter, prevent gastroesophageal reflux, enhance gastric peristalsis, promote gastric emptying, coordinate gastric and duodenal motility, inhibit nausea and vomiting, and effectively prevent bile reflux without affecting gastric juice secretion. Domperidone tablets can not easily pass the blood-cerebrospinal fluid barrier and inhibit dopamine receptors in the brain. Therefore, there are no neurological and psychiatric adverse reactions such as extrapyramidal system.
The global Domperidone market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Domperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Domperidone is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Domperidone include Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd and Hainan Asia Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Domperidone, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Domperidone.

View sample report
https://reports.valuates.com/request/sample/QYRE-Auto-25A7341/Global_Domperidone_Market_Insights_Forecast_to_2028

Report Scope
The Domperidone market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Domperidone market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Domperidone manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Get regional report
https://reports.valuates.com/request/regional/QYRE-Auto-25A7341/Global_Domperidone_Market_Insights_Forecast_to_2028

Segment by Type
• Tablets
• Pellets
• Other

Segment by Application
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Company
Schwitz Biotech, Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical, Hunan Qianjin Xiangjiang, Foshan Shouxin Pharmaceutical, Jiangxi Jiezhong Biochemistry, Meenaxy Pharma Pvt. Ltd, Hainan Asia Pharmaceutical, Lizhu Pharmaceutical Group, Jiangxi Huiren Pharmaceutical

View full report
https://reports.valuates.com/market-reports/QYRE-Auto-25A7341/global-domperidone

Valuates,
4th Floor,
Balaraj's Arcade,
Whitefield Main road,
Bangalore 560066,

Valuates offers an extensive collection of market research reports that helps companies to take intelligent strategical decisions based on current and forecasted Market trends.

This release was published on openPR.